Funding for this research was provided by:
H.F. Langbert Neuroimmunology Research Fund
Received: 2 September 2021
Accepted: 5 January 2022
First Online: 21 February 2022
: The authors declare that they have no competing interests.
: All aspects of the study protocol received full board review and approval by the Institutional Review Board at Northwell Health. Informed consent was obtained from all research participants prior to sample acquisition and health information retrieval. The study approval number is 17-0254-NSUH.